CochLear (OTCMKTS:CHEOY) Shares Gap Down – Time to Sell?

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY)’s share price gapped down prior to trading on Thursday. The stock had previously closed at $50.16, but opened at $45.29. CochLear shares last traded at $45.10, with a volume of 828 shares changing hands.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. Royal Bank Of Canada downgraded CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price objective for the company. in a report on Thursday, July 16th. Zacks Research upgraded CochLear from a “strong sell” rating to a “hold” rating in a research note on Monday, June 22nd. Jefferies Financial Group downgraded CochLear from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, July 22nd. Finally, Canaccord Genuity Group cut shares of CochLear from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 18th. Five investment analysts have rated the stock with a Hold rating, According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $117.00.

CochLear Stock Down 5.5%

The company has a fifty day moving average price of $47.04 and a two-hundred day moving average price of $45.42.

CochLear Company Profile

Cochlear Limited is an Australian medical technology company that develops, manufactures and supplies implantable hearing solutions for people with moderate to profound hearing loss. Its products are designed to help restore access to sound for individuals who may not benefit sufficiently from conventional hearing aids.

The company’s product portfolio includes cochlear implants, sound processors, bone-conduction hearing implants and related accessories and services. Cochlear also provides professional support, rehabilitation resources and connectivity solutions for recipients, hearing-health specialists and caregivers.

Founded in 1981 and headquartered in Sydney, Australia, Cochlear traces its origins to research led by Professor Graeme Clark, whose work contributed to the development of the world’s first multichannel cochlear implant.